Coherus Oncology (CHRS) Shares Issued: 2014-2024
Historic Shares Issued for Coherus Oncology (CHRS) over the last 10 years, with Dec 2024 value amounting to $241,000.
- Coherus Oncology's Shares Issued fell 48.94% to $241,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year decrease of 43.49%. This contributed to the annual value of $926,000 for FY2024, which is 48.81% down from last year.
- As of Q4 2024, Coherus Oncology's Shares Issued stood at $241,000, which was up 129.32% from -$822,000 recorded in Q2 2024.
- In the past 5 years, Coherus Oncology's Shares Issued ranged from a high of $36.6 million in Q2 2021 and a low of -$30.5 million during Q4 2021.
- Its 3-year average for Shares Issued is $561,667, with a median of $544,000 in 2022.
- In the last 5 years, Coherus Oncology's Shares Issued tumbled by 791.07% in 2021 and then soared by 1,363.11% in 2024.
- Coherus Oncology's Shares Issued (Quarterly) stood at $4.4 million in 2020, then crashed by 791.07% to -$30.5 million in 2021, then spiked by 102.18% to $665,000 in 2022, then dropped by 29.02% to $472,000 in 2023, then slumped by 48.94% to $241,000 in 2024.
- Its last three reported values are $241,000 in Q4 2024, -$822,000 for Q2 2024, and $1.5 million during Q1 2024.